Archived Newsletters

51. 03.20.25 -- February 2025 — CDMO Opportunities And Threats Report 3/20/2025
    03/20/25 Outsourced Pharma Newsletter
52. 03.19.25 -- Discover How To Optimize Productivity In Your mAb Capture 3/19/2025

    03/19/25 Outsourced Pharma Newsletter

53. 03.19.25 -- 'Fractional Hiring' At Your CDMO. Okay With You? 3/19/2025
    03/19/25 Outsourced Pharma Newsletter
54. 03.18.25 -- Your Go-To Guide For Ophthalmic Drug Development 3/18/2025

    03/18/25 Outsourced Pharma Newsletter

55. 03.18.25 -- Stop Hiring Now! Stay Virtual 3/18/2025
    03/18/25 Outsourced Pharma Newsletter
56. 03.17.25 -- STREAM Edition: Innovations, Strategies, And Tech In Today's Biopharma And Drug Development 3/17/2025

    03/17/25 Outsourced Pharma Newsletter

57. 03.17.25 -- Pain And Pleasure In Project Management Of CDMOs 3/17/2025
    03/17/25 Outsourced Pharma Newsletter
58. 03.14.25 -- EMA On Qualifying Non-Mutagenic Impurities For Drug Toxicological Safety 3/14/2025
    03/14/25 Outsourced Pharma Newsletter
59. 03.13.25 -- How To Build Resilience Amid Dynamic Biopharma Vendor Relationships 3/13/2025
    03/13/25 Outsourced Pharma Newsletter
60. 03.12.25 -- Optimize Your High Concentration Biologic Production Process 3/12/2025

    03/12/25 Outsourced Pharma Newsletter